FDA Investigator Hongna Wang
Hongna Wang has conducted inspections on 2 sites in 2 countries as of 10 Aug 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
2
Last Inspection Date:
10 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
China
FDA Investigators that have inspected at least one site in common with Hongna Wang:
Annet R Rajan,
Anthony F Lorenzo,
Anthony W Lee,
Brooke K Higgins,
Brooke K Seeman,
Carol L Rehkopf,
Carole L Jones,
Derek S Smith, PhD,
Diane T Bargo,
Diane T O'brien,
Douglas A Campbell,
Emest F Bizjak,
Ephrem Hunde, PhD,
Gerald B Seaborn, Jr,
James W Leonette,
Janet A Rajan,
Jessica Hankins, PhD,
Jonathan W Chapman,
Kathleen M Jordan,
Kelly L Anderson,
Kenneth Nieves,
LCDR Debra Emerson,
Lori S Lawless,
Malgorzata G Norton, PhD,
Marion Michaelis,
Melissa J Garcia,
Merideth K Rose,
Michael J Vardon,
Nebil A Oumer,
Nicholas A Violand,
Nicole K Trudel,
Prabhu P Raju,
Pratik S Upadhyay, DDC,
Quyen T Tran,
Rachel C Harrington,
Regina Gibson Melton,
Robert J Martin,
Sena G Dissmeyer,
Steven P Donald,
Theresa Kirkham (NMI),
Toyin B Oladimeji,
Walter L Fava,
William A Warnick,
William H Linkroum
Hongna Wang's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2019 | EIR | Cangene BioPharma, LLC - EIR, 2019-05-10 |
August, 2019 | FDA 483 | Shanghai Desano Bio-Pharmaceutical Co., Ltd. - Form 483, 2019-08-02 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more